Journal of medical case reports · 2025
Myasthenia gravis complicated by Graves' disease: a case report.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kamabu Larrey Kasereka, Oboth Ronald, Kataka Louange Maha, Baruani Albert Yemba, Lekuya Hervé Monka, Kangitsi Charles Kahindo
Аннотация
INTRODUCTION: Myasthenia gravis is a neuromuscular autoimmune condition characterized by the presence of antibodies against acetylcholine receptors. It may present as a generalized disorder or remain limited to specific muscle groups. Myasthenia gravis can occur independently or alongside other autoimmune conditions, including Hashimoto's thyroiditis and Graves' disease. Although the co-occurrence of these disorders is recognized, it is an extremely rare clinical phenomenon.
CASE PRESENTATION: A 20-year-old woman of Muganda ethnicity, with a 2-year history of Graves' disease confirmed by thyroid scintigraphy, developed a myasthenic syndrome leading to acute respiratory failure. Her condition improved with the administration of Prostigmine. Further investigations, including electrophysiological studies and immunological tests, confirmed a diagnosis of myasthenia gravis. The patient demonstrated a positive response to medical therapy.
CONCLUSION: This case highlights the importance of recognizing the rare association between myasthenia gravis and Graves' disease. Accurate diagnosis and effective treatment require a coordinated, multidisciplinary approach, particularly given the challenges posed by overlapping symptoms and the exacerbating effects of hyperthyroidism on myasthenia gravis.
CASE PRESENTATION: A 20-year-old woman of Muganda ethnicity, with a 2-year history of Graves' disease confirmed by thyroid scintigraphy, developed a myasthenic syndrome leading to acute respiratory failure. Her condition improved with the administration of Prostigmine. Further investigations, including electrophysiological studies and immunological tests, confirmed a diagnosis of myasthenia gravis. The patient demonstrated a positive response to medical therapy.
CONCLUSION: This case highlights the importance of recognizing the rare association between myasthenia gravis and Graves' disease. Accurate diagnosis and effective treatment require a coordinated, multidisciplinary approach, particularly given the challenges posed by overlapping symptoms and the exacerbating effects of hyperthyroidism on myasthenia gravis.